Atherosclerosis Supplements

14.4k citations
624 papers · · active since 2000

Impact in

  • Surgery top 10%
    • Lipoproteins and Cardiovascular Health
    • Cholesterol and Lipid Metabolism
    • Fatty Acid Research and Health

Papers in

Atherosclerosis Supplements

603 papers receiving 13.7k citations

Peers

Atherosclerosis Supplements
Comparison fields: 5 of 158
  • Surgery 6.1k
  • Nutrition and Dietetics 1.1k
  • Cardiology and Cardiovascular Medicine 1.8k
  • Endocrinology, Diabetes and Metabolism 913
  • Clinical Biochemistry 254
Replace Cardiovascular Therapeutics with:
Cardiovascular Therapeutics China
Advances in Chronic Kidney Disease United States
North American Journal of Medical Sciences India
Critical Reviews in Clinical Laboratory Sciences United States
Advances in clinical chemistry United States
Diabetes and Vascular Disease Research United States
Journal of Intensive Care Japan
Current Cardiology Reviews United States
Acta Cardiologica Türkiye
Circulation Cardiovascular Genetics United States
Atherosclerosis Supplements relative to Cardiovascular Therapeutics China Cardiovascular Therapeutics's profile →
Citations per field
00.5×2×3.2×
Cardiovascular Therapeutics · 1×
Citations per year

Countries where authors publish in Atherosclerosis Supplements

Since Specialization
Citations

This map shows the geographic impact of research published in Atherosclerosis Supplements. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers published in Atherosclerosis Supplements with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Atherosclerosis Supplements more than expected).

Fields of papers published in Atherosclerosis Supplements

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers published in Atherosclerosis Supplements. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers published in Atherosclerosis Supplements.

About Atherosclerosis Supplements

The 624 papers published in Atherosclerosis Supplements in the last decades have received a total of 14.4k indexed citations . Papers published in Atherosclerosis Supplements usually cover Surgery (376 papers), Cardiology and Cardiovascular Medicine (97 papers), Nutrition and Dietetics (34 papers), Immunology (50 papers) and Clinical Biochemistry (12 papers) specifically the topics of Lipoproteins and Cardiovascular Health (324 papers), Cholesterol and Lipid Metabolism (61 papers), Atherosclerosis and Cardiovascular Diseases (47 papers), Lipid metabolism and disorders (46 papers), Fatty Acid Research and Health (30 papers), Nitric Oxide and Endothelin Effects (26 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (22 papers) and Cardiovascular Health and Disease Prevention (13 papers). The most active scholars publishing in Atherosclerosis Supplements are Terje Rolf Pedersen, Philip J. Barter, John P. Cooke, Marja‐Riitta Taskinen, Yūji Matsuzawa, Naveed A. Sattar, Karsten Sydow, Thomas Münzel, M. John Chapman and Ulrich Julius.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore journals with similar magnitude of impact